Current $57, target $71 = 24.5% upside. DCF FV $129 (P(above)=100%) suggests strong fundamental upside. Thesis: 80% recurring revenue + Clover growth optionality at fintech scale. Missing element: $29B debt load (8x EBIT) + leadership transition — cant go to 8 until debt trajectory confirmed improving and Clover shows unit economics at scale.
Fair Value Distribution — percentile bands
100.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
-8.2%/yr
±1.9% · revenue growth to justify current price
FCF-Based Reverse DCF
-1.0%/yr
±2.5% · FCF growth to justify current price
THE GAP
Market pricing margin compression or rising capex
KEY VALUE DRIVERS
Spearman correlation — what moves this valuation most
Eagle will generate this view by the next trading session (~6h).
Eagle will generate this view by the next trading session (~6h).
FISV Q4 miss but debt now 3x EBITDA (key overhang clearing). Clover 23% 2025, guided 10-15% 2026. Stock at 56 = 7x adj EPS, 130% discount to DCF FV 129. Maintain conviction 7. Watch Q1 April 23 for Cl...
FISV: Stable recurring revenue fortress with debt/execution headwinds. 80% non-discretionary processing/services, strong cash generation, but transformation risk and elevated leverage require caution....